Online Opportunities and Responsibility
By Mark Land, AAHP President As our article on online marketing techniques shows, there’s great opportunity to increase product awareness and sales. But take caution; Do not do so at…
Read MoreHomeopathy Consumers Are Online. Are You?
Online Marketing Techniques for Homeopathic Manufacturers | Many of today’s consumers are looking for natural, safe, and effective drug products—and that means they’re turning to homeopathy. In fact, at our Summit event last spring, industry consulting firm The Emerson Group shared recent homeopathy sales numbers of $1.1 billion!
Read More3 Homeopathic Compliance Hot Spots to Watch
All drug products, homeopathic and allopathic alike, must be safe and effective. That means they have to be manufactured correctly, containing only the ingredients and potencies they claim to have. In short, all drugs must comply with Current Good Manufacturing Practice (CGMP). It is not only FDA’s responsibility to ensure these medications fulfill the CGMP requirements of safety, identity, strength, quality, and purity—it’s the industry’s responsibility, too.
Read MoreHow to Submit Monographs to the HPUS
FDA’s Revised Draft Enforcement Document states the Agency considers only products that use substances monographed in the Homeopathic Pharmacopoeia of the United States (HPUS) as homeopathic. This statement has created interest…
Read MoreFDA Comment Period Extended: Help AAHP Present Manufacturers’ Voice
AAHP is preparing comments to “FDA Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry.” Initially published in December 2017, the guidance was revised and republished…
Read MoreAAHP’s Views on Aspects of FDA’s Revised Draft Guidance
Since 2015, the Food and Drug Administration (FDA) has been engaged in a reevaluation of Compliance Policy Guide 400.400, Conditions under Which Homeopathic Drugs May Be Marketed. FDA issued a…
Read MoreAAHP 2019: Reawakening the Regulatory and Retail Dialog
By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality. AAHP has been there for…
Read MoreTrump Nominates New FDA Commissioner
Senate Hearing Set for Nov. 20 By Pete Evich, AAHP Govt. Relations On Nov. 1, President Trump nominated Stephen Hahn, chief medical executive of the MD Anderson Cancer Center…
Read More4 Types of FDA Inspections & How to Prepare
Risk. It’s a hot word in the homeopathic industry right now. Even before the FDA issued its draft guidance, the agency used a risk-based approach to site inspections. With the…
Read MoreLittle-Known Facts About 3 Unique Starting Materials
By Mary Beth Watkins and Eric Foxman The array of substances used for homeopathic drug products is wide and varied. Many homeopathic starting materials also have uses outside of…
Read More